BMT CTN Protocol 0801

A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus plus Prednisone, and Sirolimus/Calcineurin Inhibitor plus Prednisone for the Treatment of Chronic Graft-versus-Host Disease

Below are protocol-related documents, which may be periodically updated.

            Protocol co-Chair: Paul Carpenter, MD, BS (206-667-5191) pcarpent@fhcrc.org

            Protocol co-Chair: Mukta Arora, MD arora005@umn.edu

            Protocol Officer: Marcelo Pasquini, MD (414-805-0700) mpasquin@mcw.edu

            Protocol Coordinator: Kelly O'Brien (301-251-1161) kobrien@emmes.com

            Medical Monitor: Bipin Savani bipin.savani@vanderbilt.edu

 

How to Conduct a Comprehensive Chronic GVHD Assessment” is an instructional guide for centers participating in the BMT CTN cGVHD 0801 protocol.  The video also may serve as a tool to help obtain greater impartiality for clinical research trials focusing on cGVHD, and provides a more definitive method for assessing patients with cGVHD.

The BMT CTN 0801 study closed to new patient accrual on December 9, 2013.